Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor

This trial is no longer accepting participants. For information / assistance to help you learn what clinical trials are right for you, please call Cancer AnswerLine at 800-865-1125.